African Pharmaceutical Market to Grow at 6–8% CAGR by 2029, Driven by Rising Demand and Investment

The African pharmaceutical market is poised for substantial growth between 2024 and 2029, with an expected CAGR of 6–8%. Driven by a combination of factors-including a rising population, increasing urbanization, growing incidence of chronic diseases, and greater healthcare expenditure-the market presents compelling opportunities for investors, global pharmaceutical companies, and regional manufacturers alike.

Despite persistent challenges such as underdeveloped healthcare infrastructure and the high cost of drug manufacturing, the African pharmaceutical sector is witnessing accelerated transformation and expansion. As governments and international agencies ramp up efforts to strengthen public health systems, the market's outlook remains optimistic.

📌 Request a Sample Report for In-depth Market Trends and Data.

Rapid Growth and Investment Opportunities in the African Pharmaceutical Sector

Africa’s pharmaceutical industry remains relatively underdeveloped when compared to global standards. However, this gap provides a unique opportunity for market entrants and established players seeking untapped potential.

Key Drivers of Market Expansion

• Urbanization & Population Growth: Rapid urbanization is creating dense urban centers, leading to greater demand for healthcare services and pharmaceutical products.
• Increased Health Awareness: With more awareness about communicable and non-communicable diseases, healthcare-seeking behavior is on the rise.
• Government Reforms: Several African governments are modernizing their healthcare policies to encourage foreign direct investment (FDI) and promote domestic pharmaceutical production.
• Disease Burden: The continent remains highly vulnerable to infectious diseases like Malaria, Cholera, TB, HIV/AIDS, and emerging outbreaks. These continue to generate high demand for essential and life-saving drugs.

Case in Point: Malaria Vaccination

Malaria remains one of Africa’s deadliest diseases, especially among children under five. According to the World Health Organization (WHO), more than 260,000 African children die each year due to malaria. In a landmark move, WHO approved the RTS,S/AS01 malaria vaccine in 2021 for use in children across sub-Saharan Africa-a development expected to fuel pharmaceutical market growth in the region.

“This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health, and malaria control.” - WHO Director-General

Non-Communicable Diseases Drive Demand for Chronic Medication

Africa is also seeing a shift toward a Westernized lifestyle, contributing to a surge in non-communicable diseases (NCDs) like diabetes, cardiovascular diseases, hypertension, and cancer. These conditions necessitate long-term treatment, thereby increasing demand for chronic prescription drugs.

Governments are actively working to improve healthcare infrastructure, expand insurance coverage, and make essential medicines more accessible. The increased penetration of e-commerce platforms is also aiding the distribution and availability of pharmaceuticals across remote areas.

Market Structure and Product Segmentation

The African pharmaceutical market is segmented into:

• Generic Drugs: Dominating the market due to affordability and wide accessibility. Governments and NGOs heavily promote generics to meet healthcare demands cost-effectively.
• Branded Drugs: While holding a smaller share, branded drugs are vital for chronic and specialized treatments. These are primarily offered by multinational corporations.
• Over-the-Counter (OTC) Medications: Popular among consumers for treating common ailments like cold, flu, and headaches without prescriptions.

📌 Explore in-depth segmentation data and growth trends - Download the Sample Report.

Challenges Impacting Market Growth

Despite promising potential, several structural and regulatory issues hamper growth:

• Fragmented Market Landscape: Africa consists of 54 countries, each with varying regulatory standards, trade barriers, and healthcare policies.
• Supply Chain Inefficiencies: Poor procurement systems and lack of coordination across health ministries lead to medicine shortages.
• Low R&D Investment: There is limited funding and infrastructure for pharmaceutical research and innovation.
• Dependency on Imports: Over 70% of pharmaceuticals are imported, creating vulnerabilities in drug supply and pricing.

Government and Private Sector Initiatives Fueling Progress

Notable Developments

• African Pharmaceutical Technology Foundation: Launched in November 2022 by the African Development Bank to foster vaccine and drug manufacturing capacity across the continent.
• Biovac’s mRNA Vaccine Production Agreement: In July 2021, Biovac entered into a landmark partnership with Pfizer and BioNTech to produce the Pfizer-BioNTech COVID-19 vaccine in Africa.
• Aspen & NTC Partnership: In 2021, NTC (Italy) and Aspen (South Africa) launched the first fixed-dose eye drop solution combining a quinolone antibiotic and a steroid, approved by the South African Health Products Regulatory Authority (SAHPRA).

These initiatives highlight the increasing collaboration between local firms, governments, and global pharmaceutical giants.

Competitive Landscape: Key Players in the African Pharmaceutical Market

Leading market players are adopting a combination of organic and inorganic strategies to establish their footprint in the African market. These include:

• Adcock Ingram
• Pfizer Inc.
• Novartis AG
• Johnson & Johnson
• Sanofi
• Bayer
• Cipla
• Aspen Pharmacare
• Merck & Co.

These companies are focusing on new product launches, local partnerships, and capacity-building programs to drive long-term success.

Strategic Highlights

• August 2023: Africa CDC contributed USD 750,000 worth of equipment to SAHPRA to boost vaccine regulatory oversight.
• April 2023: WHO and South Korea signed an agreement to launch a global biomanufacturing training hub in South Africa.
• December 2022: Aspen received USD 30 million in funding from the Bill & Melinda Gates Foundation and CEPI to expand vaccine production for routine immunization and pandemic preparedness.

Future Outlook and Market Opportunities

The African pharmaceutical market is expected to continue its upward trajectory due to:

• A rising population expected to double by 2050.
• Increased demand for essential, generic, and chronic disease drugs.
• Growing support from international agencies and private investors.
• Enhanced regulatory and distribution infrastructure.

As local manufacturing capabilities grow and digital health solutions become more widespread, the market is likely to become more self-sufficient and attractive to investors globally.

Related Market Research Reports

• Nanopore Sequencing Market Forecast to 2030
• Optical Imaging Market Trends and Growth Forecast
• Clinical Trial Supplies Market Outlook to 2030

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/